18F-fluorodeoxyglucose position emission tomography (FDG-PET) for monitoring disease activity and treatment response in idiopathic retroperitoneal fibrosis-Reference-Cited by-同舟云学术

18F-fluorodeoxyglucose position emission tomography (FDG-PET) for monitoring disease activity and treatment response in idiopathic retroperitoneal fibrosis

Published:2010-06 Issue:3 Volume:21 Page:216-221
ISSN:0953-6205
Container-title:European Journal of Internal Medicine
language:en
Short-container-title:European Journal of Internal Medicine

Author:

Jansen I.,Hendriksz T.R.,Han S.H.,Huiskes A.W.L.C.,van Bommel E.F.H.

Publisher

Elsevier BV

Subject

Internal Medicine

Reference33 articles.

1. Retroperitoneal fibrosis;Van Bommel;Neth J Med,2002

2. Retroperitoneal fibrosis;Vaglio;Lancet,2006

3. Idiopathic retroperitoneal fibrosis: prospective evaluation of incidence and clinicoradiological presentation;Van Bommel;Medicine,2009

4. Long-term renal and patient outcome in idiopathic retroperitoneal fibrosis treated with prednisone;Van Bommel;Am J Kidney Dis,2007

5. FDG-PET for imaging of non-osseous infection and inflammation;Vos;J Nucl Med Mol Im,2006

Cited by 65 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Extravertebral low back pain: a scoping review;BMC Musculoskeletal Disorders;2024-05-07

2. Overview of F18-FDG uptake patterns in retroperitoneal pathologies: imaging findings, pitfalls, and artifacts;Abdominal Radiology;2024-04-23

3. Rituximab in the management of retroperitoneal fibrosis: A single tertiary rheumatology care center experience;International Journal of Rheumatic Diseases;2023-06-26

4. Successful therapy of retroperitoneal fibrosis due to IgG4-related disease with rituximab, cyclophosphamide and glucocorticoids followed by maintenance therapy wit ritutixmab;Vnitřní lékařství;2023-05-16

5. Potential applications of PET/MRI in non-oncologic conditions within the abdomen and pelvis;Abdominal Radiology;2023-05-05